Ro Khanna actually said...

Would you say that in the case of Copaxone where Teva is asking for more patents... that could be frivolous?

Context

Khanna questions the validity of multiple patents extending drug prices.

04/10/2024

https://congress.gov...

More Ro Khanna Quotes

View All Ro Khanna Quotes